申请人:Mitsubishi Tanabe Pharma Corporation
公开号:US07410984B2
公开(公告)日:2008-08-12
The present invention relates to novel pyridone derivatives capable of inhibiting α4 integrin mediated cell adhesion, processes for their preparation, compositions comprising them and their use in the treatment of diseases capable of being modulated by the inhibition of cell adhesion.
本发明涉及一种新型吡啶酮衍生物,能够抑制α4整合素介导的细胞黏附,其制备方法,包含它们的组合物以及它们在治疗能够通过抑制细胞黏附来调节的疾病中的应用。